Chris is a compliance and regulatory professional with more than 30 years of life science industry experience. He specializes in assisting health & life sciences companies to address global third-party risk and implement compliance improvement strategies.
He works closely with management teams, chief compliance officers, legal counsel and operational leads to identify and implement improvements to their compliance program. Chris also assists clients in fraud investigations, compliance inquires and in strategizing responses to government subpoenas and other requests.
Prior to joining Ernst & Young LLP, he was the Sr. Director Risk Mitigation and CIA Management for the Pharmaceutical Sector of Johnson & Johnson. He was responsible for the development and implementation of a comprehensive global compliance program and has first-hand experience managing and responding to government investigations, including the negotiation of settlement agreements.
How Chris is building a better working world
“I am dedicated to helping clients identify and address compliance assessment needs and to conduct analyses to identify non-compliant outcomes and behaviors. I work closely with all levels of a client’s organization to identify and prevent enforcement risks and to recommend and implement solutions that bring value to both the business and compliance. In doing so, I combine personal subject matter experience with knowledge of industry leading practices to bring deliver client-specific solutions that address their needs today while preparing them to proactively mitigate future risk.”